{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T10:09:16Z","timestamp":1756894156624,"version":"3.41.2"},"reference-count":31,"publisher":"Federa\u00e7\u00e3o das Associa\u00e7\u00f5es de Ginecologia e Obstetr\u00edcia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,14]]},"DOI":"10.61622\/rbgo\/2024ao18","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T15:41:53Z","timestamp":1714664513000},"source":"Crossref","is-referenced-by-count":3,"title":["Real-world utilization pattern of dydrogesterone in 7287 Indian women with obstetric and gynecological conditions: data from multicentric, retrospective study"],"prefix":"10.61622","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7032-8041","authenticated-orcid":false,"given":"Jaydeep","family":"Tank","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8730-3896","authenticated-orcid":false,"given":"Sanjay","family":"Gupte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2270-7691","authenticated-orcid":false,"given":"Purna Chandra","family":"Mahapatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8056-1710","authenticated-orcid":false,"given":"Jayanthi","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3268-3681","authenticated-orcid":false,"given":"Pratima","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6521-139X","authenticated-orcid":false,"given":"Ashish Kumar","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6881-9827","authenticated-orcid":false,"given":"Lila","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8187-2606","authenticated-orcid":false,"given":"Achla","family":"Batra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0490-5152","authenticated-orcid":false,"given":"Mahesh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6969-1119","authenticated-orcid":false,"given":"Sunita","family":"Tandulwadkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9343-6230","authenticated-orcid":false,"given":"Sunita","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4311-9557","authenticated-orcid":false,"given":"Vidya","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2945-0158","authenticated-orcid":false,"given":"Kawita","family":"Bapat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9515-6769","authenticated-orcid":false,"given":"Parikshit","family":"Tank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3247-9218","authenticated-orcid":false,"given":"Ketan","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6006-7520","authenticated-orcid":false,"given":"Onkar","family":"Swami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"47794","reference":[{"issue":"4","key":"key20240502114141_B1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/09513590.2021.2016692","article-title":"Dydrogesterone after 60 years: a glance at the safety profile","volume":"38","author":"Ott","year":"2022","unstructured":"Ott J, Egarter C, Aguilera A. Dydrogesterone after 60 years: a glance at the safety profile. Gynecol Endocrinol. 2022;38(4):279-87. doi: 10.1080\/09513590.2021.2016692","journal-title":"Gynecol Endocrinol"},{"key":"key20240502114141_B2","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-52508-8","volume-title":"Progestogens in obstetrics and gynecology","author":"Carp","year":"2021","unstructured":"Carp HJ. Progestogens in obstetrics and gynecology. 2nd ed. Cham: Springer Nature; 2021.","edition":"2nd ed."},{"key":"key20240502114141_B3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/aogs.12791","article-title":"Clinical roles and applications of progesterone in reproductive medicine: an overview","volume":"94","author":"Filicori","year":"2015","unstructured":"Filicori M. Clinical roles and applications of progesterone in reproductive medicine: an overview. Acta Obstet Gynecol Scand. 2015;94 Suppl 161:3-7. doi: 10.1111\/aogs.12791","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"11","key":"key20240502114141_B4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241044","article-title":"Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: a systematic review and individual participant data meta-analysis","volume":"15","author":"Griesinger","year":"2020","unstructured":"Griesinger G, Blockeel C, Kahler E, Pexman-Fieth C, Olofsson JI, Driessen S, et al. Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: a systematic review and individual participant data meta-analysis. PLoS One. 2020;15(11):e0241044. doi: 10.1371\/journal.pone.0241044","journal-title":"PLoS One"},{"issue":"2","key":"key20240502114141_B5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.rbmo.2018.11.017","article-title":"Dydrogesterone: pharmacological profile and mechanism of action as luteal phase support in assisted reproduction","volume":"38","author":"Griesinger","year":"2019","unstructured":"Griesinger G, Tournaye H, Macklon N, Petraglia F, Arck P, Blockeel C, et al. Dydrogesterone: pharmacological profile and mechanism of action as luteal phase support in assisted reproduction. Reprod Biomed Online. 2019;38(2):249-59. doi: 10.1016\/j.rbmo.2018.11.017","journal-title":"Reprod Biomed Online"},{"issue":"6","key":"key20240502114141_B6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.steroids.2011.02.043","article-title":"Selectivity and potency of the retroprogesterone dydrogesterone in vitro","volume":"76","author":"Ri\u017ener","year":"2011","unstructured":"Ri\u017ener TL, Bro\u017ei\u010d P, Doucette C, Turek-Etienne T, M\u00fcller-Vieira U, Sonneveld E, et al. Selectivity and potency of the retroprogesterone dydrogesterone in vitro. Steroids. 2011;76(6):607-15. doi: 10.1016\/j.steroids.2011.02.043","journal-title":"Steroids"},{"issue":"6","key":"key20240502114141_B7","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3109\/09513590.2015.1006618","article-title":"A systematic review of dydrogesterone for the treatment of recurrent miscarriage","volume":"31","author":"Carp","year":"2015","unstructured":"Carp H. A systematic review of dydrogesterone for the treatment of recurrent miscarriage. Gynecol Endocrinol. 2015;31(6):422-30. doi: 10.3109\/09513590.2015.1006618","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"key20240502114141_B8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.earlhumdev.2008.12.016","article-title":"Dydrogesterone use during pregnancy: 0verview of birth defects reported since 1977","volume":"85","author":"Queisser-Luft","year":"2009","unstructured":"Queisser-Luft A. Dydrogesterone use during pregnancy: 0verview of birth defects reported since 1977. Early Hum Dev. 2009;85(6):375-7. doi: 10.1016\/j.earlhumdev.2008.12.016","journal-title":"Early Hum Dev"},{"issue":"2","key":"key20240502114141_B9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.rbmo.2022.03.032","article-title":"A critical appraisal of safety data on dydrogesterone for the support of early pregnancy: a scoping review and meta-analysis","volume":"45","author":"Katalinic","year":"2022","unstructured":"Katalinic A, Shulman LP, Strauss JF, Garcia-Velasco JA, van den Anker JN. A critical appraisal of safety data on dydrogesterone for the support of early pregnancy: a scoping review and meta-analysis. Reprod BioMed Online. 2022;45(2):365-73. doi: 10.1016\/j.rbmo.2022.03.032","journal-title":"Reprod BioMed Online"},{"issue":"2","key":"key20240502114141_B10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/uog.15814","article-title":"Dydrogesterone vs progesterone for luteal-phase support: systematic review and meta-analysis of randomized controlled trials","volume":"48","author":"Barbosa","year":"2016","unstructured":"Barbosa MW, Silva LR, Navarro PA, Ferriani RA, Nastri CO, Martins WP. Dydrogesterone vs progesterone for luteal-phase support: systematic review and meta-analysis of randomized controlled trials. Ultrasound Obstet Gynecol. 2016;48(2):161-70. doi: 10.1002\/uog.15814","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"key20240502114141_B11","first-page":"4544","article-title":"Effect of dydrogesterone and progesterone on threatened miscarriage due to corpus luteum insufficiency","volume":"13","author":"Lou","year":"2021","unstructured":"Lou C, Wang C, Zhao Q, Jin F. Effect of dydrogesterone and progesterone on threatened miscarriage due to corpus luteum insufficiency. Am J Transl Res. 2021;13(5):4544-52.","journal-title":"Am J Transl Res"},{"issue":"1","key":"key20240502114141_B12","first-page":"11","article-title":"To study the comparison between oral dydrogesterone and micronized progesterone in threatened miscarriage in terms of pain lower abdomen and bleeding per vaginum","volume":"7","author":"Verma","year":"2020","unstructured":"Verma S, Yadav P. To study the comparison between oral dydrogesterone and micronized progesterone in threatened miscarriage in terms of pain lower abdomen and bleeding per vaginum. Ann Int Med Dent Res. 2020;7(1):11-5.","journal-title":"Ann Int Med Dent Res"},{"issue":"3","key":"key20240502114141_B13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.13707","article-title":"A pairwise and network meta-analysis comparing the efficacy and safety of progestogens in threatened abortion","volume":"156","author":"Zhao","year":"2022","unstructured":"Zhao H, He W, Yang Z. A pairwise and network meta-analysis comparing the efficacy and safety of progestogens in threatened abortion. Int J Gynaecol Obstet. 2022;156(3):383-93. doi: 10.1002\/ijgo.13707","journal-title":"Int J Gynaecol Obstet"},{"issue":"10","key":"key20240502114141_B14","doi-asserted-by":"crossref","first-page":"10971","DOI":"10.21037\/apm-21-2605","article-title":"Efficacy of dydrogesterone on treating recurrent miscarriage and its influence on immune factors: a systematic review and meta-analysis","volume":"10","author":"Guo","year":"2021","unstructured":"Guo H, Lu Q. Efficacy of dydrogesterone on treating recurrent miscarriage and its influence on immune factors: a systematic review and meta-analysis. Ann Palliat Med. 2021;10(10):10971-85. doi: 10.21037\/apm-21-2605","journal-title":"Ann Palliat Med"},{"issue":"6","key":"key20240502114141_B15","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.fertnstert.2021.07.1194","article-title":"Prolonged cyclical and continuous regimens of dydrogesterone are effective for reducing chronic pelvic pain in women with endometriosis: results of the ORCHIDEA study","volume":"116","author":"Sukhikh","year":"2021","unstructured":"Sukhikh GT, Adamyan LV, Dubrovina SO, Baranov II, Bezhenar VF, Kozachenko AV, et al. Prolonged cyclical and continuous regimens of dydrogesterone are effective for reducing chronic pelvic pain in women with endometriosis: results of the ORCHIDEA study. Fertil Steril. 2021;116(6):1568-77. doi: 10.1016\/j.fertnstert.2021.07.1194","journal-title":"Fertil Steril"},{"issue":"15","key":"key20240502114141_B16","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.12998\/wjcc.v8.i15.3259","article-title":"Dydrogesterone treatment for menstrual-cycle regularization in abnormal uterine bleeding \u2013 ovulation dysfunction patients","volume":"8","author":"Wang","year":"2020","unstructured":"Wang L, Guan HY, Xia HX, Chen XY, Zhang W. Dydrogesterone treatment for menstrual-cycle regularization in abnormal uterine bleeding \u2013 ovulation dysfunction patients. World J Clin Cases. 2020;8(15):3259-66. doi: 10.12998\/wjcc.v8.i15.3259","journal-title":"World J Clin Cases"},{"issue":"11","key":"key20240502114141_B17","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/09513590701582554","article-title":"Cyclical dydrogesterone in secondary amenorrhea: results of a double-blind, placebo-controlled, randomized study","volume":"23","author":"Panay","year":"2007","unstructured":"Panay N, Pritsch M, Alt J. Cyclical dydrogesterone in secondary amenorrhea: results of a double-blind, placebo-controlled, randomized study. Gynecol Endocrinol. 2007;23(11):611-8. doi: 10.1080\/09513590701582554","journal-title":"Gynecol Endocrinol"},{"issue":"8","key":"key20240502114141_B18","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3109\/09513590.2016.1152238","article-title":"Effectiveness and safety of dydrogesterone in regularization of menstrual cycle: a post-marketing study","volume":"32","author":"Trivedi","year":"2016","unstructured":"Trivedi N, Chauhan N, Vaidya V. Effectiveness and safety of dydrogesterone in regularization of menstrual cycle: a post-marketing study. Gynecol Endocrinol. 2016;32(8):667-71. doi: 10.3109\/09513590.2016.1152238","journal-title":"Gynecol Endocrinol"},{"issue":"7316","key":"key20240502114141_B19","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/bmj.323.7316.776","article-title":"Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review","volume":"323","author":"Wyatt","year":"2001","unstructured":"Wyatt K, Dimmock P, Jones P, Obhrai M, O'Brien S. Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review. BMJ. 2001;323(7316):776-80. doi: 10.1136\/bmj.323.7316.776","journal-title":"BMJ"},{"issue":"2","key":"key20240502114141_B20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/jcpt.13536","article-title":"Real-world pharmacological treatment patterns of patients with threatened miscarriage in China from 2014 to 2020: a cross-sectional analysis","volume":"47","author":"Pang","year":"2022","unstructured":"Pang YY, Ma CL. Real-world pharmacological treatment patterns of patients with threatened miscarriage in China from 2014 to 2020: a cross-sectional analysis. J Clin Pharm Ther. 2022;47(2):228-36. doi: 10.1111\/jcpt.13536","journal-title":"J Clin Pharm Ther"},{"volume-title":"Dydrofem (Dydrogesterone tablets IP 10 mg)","year":"2020","key":"key20240502114141_B21","unstructured":"Dydrofem (Dydrogesterone tablets IP 10 mg). Pune: Emcure Pharmaceuticals; 2020."},{"issue":"6","key":"key20240502114141_B22","first-page":"442","article-title":"Habitual abortion","volume":"72","author":"Benson","year":"1950","unstructured":"Benson RC. Habitual abortion. Calif Med. 1950;72(6):442-6.","journal-title":"Calif Med"},{"issue":"4","key":"key20240502114141_B23","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3390\/cells11040647","article-title":"Progesterone actions and resistance in gynecological disorders","volume":"11","author":"MacLean","year":"2022","unstructured":"MacLean JA 2nd, Hayashi K. Progesterone actions and resistance in gynecological disorders. Cells. 2022;11(4):647. doi: 10.3390\/cells11040647","journal-title":"Cells"},{"issue":"5","key":"key20240502114141_B24","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/humrep\/dex023","article-title":"A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization","volume":"32","author":"Tournaye","year":"2017","unstructured":"Tournaye H, Sukhikh GT, Kahler E, Griesinger G. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization. Hum Reprod. 2017;32(5):1019-27. doi: 10.1093\/humrep\/dex023","journal-title":"Hum Reprod"},{"key":"key20240502114141_B25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/09513590701584857","article-title":"Modulating fertility outcome in assisted reproductive technologies by the use of dydrogesterone","volume":"23","author":"Patki","year":"2007","unstructured":"Patki A, Pawar VC. Modulating fertility outcome in assisted reproductive technologies by the use of dydrogesterone. Gynecol Endocrinol. 2007;23 Suppl 1:68-72. doi: 10.1080\/09513590701584857","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"key20240502114141_B26","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.fertnstert.2011.01.148","article-title":"Comparison of oral dydrogestrone with progesterone gel and micronized progesterone for luteal support in 1,373 women undergoing in vitro fertilization: a randomized clinical study","volume":"95","author":"Ganesh","year":"2011","unstructured":"Ganesh A, Chakravorty N, Mukherjee R, Goswami S, Chaudhury K, Chakravarty B. Comparison of oral dydrogestrone with progesterone gel and micronized progesterone for luteal support in 1,373 women undergoing in vitro fertilization: a randomized clinical study. Fertil Steril. 2011;95(6):1961-5. doi: 10.1016\/j.fertnstert.2011.01.148","journal-title":"Fertil Steril"},{"key":"key20240502114141_B27","volume-title":"StatPearls","author":"Mouri","year":"2022","unstructured":"Mouri Mi, Hall H, Rupp TJ. Threatened abortion. In: StatPearls. Treasure Island: StatPearls Publishing; 2022 [cited 2022 Oct 14]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK430747\/"},{"issue":"1","key":"key20240502114141_B28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.15296\/ijwhr.2017.05","article-title":"Infertility-related risk factors: a systematic review","volume":"5","author":"Deyhoul","year":"2017","unstructured":"Deyhoul N, Mohamaddoost T, Hosseini M. Infertility-related risk factors: a systematic review. Int J Womens Health Reprod Sci. 2017;5(1):24-9. doi: 10.15296\/ijwhr.2017.05","journal-title":"Int J Womens Health Reprod Sci"},{"key":"key20240502114141_B29","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.2105\/AJPH.2013.301583","article-title":"Trends in maternal morbidity before and during pregnancy in California","volume":"104","author":"Fridman","year":"2014","unstructured":"Fridman M, Korst LM, Chow J, Lawton E, Mitchell C, Gregory KD. Trends in maternal morbidity before and during pregnancy in California. Am J Public Health. 2014;104 Suppl 1:S49-57. doi: 10.2105\/AJPH.2013.301583","journal-title":"Am J Public Health"},{"issue":"7","key":"key20240502114141_B30","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/humrep\/deab093","article-title":"Micronized progesterone plus dydrogesterone versus micronized progesterone alone for luteal phase support in frozen-thawed cycles (MIDRONE): a prospective cohort study","volume":"36","author":"Vuong","year":"2021","unstructured":"Vuong LN, Pham TD, Le KT, Ly TT, Le HL, Nguyen DT, et al. Micronized progesterone plus dydrogesterone versus micronized progesterone alone for luteal phase support in frozen-thawed cycles (MIDRONE): a prospective cohort study. Hum Reprod. 2021;36(7):1821-31. doi: 10.1093\/humrep\/deab093","journal-title":"Hum Reprod"},{"issue":"7","key":"key20240502114141_B31","doi-asserted-by":"crossref","first-page":"102110","DOI":"10.1016\/j.jogoh.2021.102110","article-title":"Comparison of vaginal progesterone gel combined with oral dydrogesterone versus intramuscular progesterone for luteal support in hormone replacement therapy-frozen embryo transfer cycle","volume":"50","author":"Xu","year":"2021","unstructured":"Xu H, Zhang XQ, Zhu XL, Weng HN, Xu LQ, Huang L, et al. Comparison of vaginal progesterone gel combined with oral dydrogesterone versus intramuscular progesterone for luteal support in hormone replacement therapy-frozen embryo transfer cycle. J Gynecol Obstet Hum Reprod. 2021;50(7):102110. doi: 10.1016\/j.jogoh.2021.102110","journal-title":"J Gynecol Obstet Hum Reprod"}],"container-title":["Revista Brasileira de Ginecologia e Obstetr\u00edcia \/ RBGO Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journalrbgo.org\/wp-content\/uploads\/sites\/4\/articles_xml\/1806-9339-rbgo-46-e-rbgo18\/1806-9339-rbgo-46-e-rbgo18.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T16:52:30Z","timestamp":1724345550000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalrbgo.org\/article\/real-world-utilization-pattern-of-dydrogesterone-in-7287-indian-women-with-obstetric-and-gynecological-conditions-data-from-multicentric-retrospective-study\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":31,"alternative-id":["10.61622\/rbgo\/2024AO18"],"URL":"https:\/\/doi.org\/10.61622\/rbgo\/2024ao18","relation":{},"ISSN":["0100-7203","1806-9339"],"issn-type":[{"type":"print","value":"0100-7203"},{"type":"electronic","value":"1806-9339"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e-rbgo18"}}